INEYE THERAPEUTICS, founded in 2017, is a promising startup dedicated to the innovation of biomaterials and devices for ocular applications. Operating from its headquarters in Portugal, the company aligns itself with its mission statement, "Healthy eyes for a lifetime".
The startup recently attracted a €100.00K Pre Seed Round investment on 18 September 2023, with Portugal Ventures as the investing partner. This financial backing underscores the market’s confidence in INEYE THERAPEUTICS's potential to advance in the ocular sector.
Despite being relatively young, the company appears committed to carving a niche within an evolving market, largely untapped by competitors focusing on biomaterials for eye care. As such, it offers appealing potential for investors looking to support groundbreaking innovations in healthcare technology.